Annemarie van der Aart-van der Beek

If you made any changes in Pure these will be visible here soon.

Kidney and heart failure outcomes associated with SGLT2 inhibitor use
Van der Aart-van der Beek, A. B., de Boer, R. A. & Heerspink, H. J. L., May-2022, In: Nature Reviews Nephrology. 18, 5, p. 294-306 13 p.
Research output: Contribution to journal › Review article › Academic › peer-review
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease
van der Aart-van der Beek, A. B., Koomen, J. V., Dekkers, C. C. J., Barbour, S. J., Boulton, D. W., Gansevoort, R. T., Greasley, P. J., Abdul Gafor, A. H., Laverman, G. D., Li, Q., Lim, S. K., Stevens, J., Vervloet, M. G., Singh, S., Cattran, D. C., Reich, H. N., Cherney, D. Z. I. & Heerspink, H. J. L., 15-Feb-2021, In: Clinical Pharmacokinetics. 9 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

100 Downloads (Pure)

Network